These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37751084)
1. Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry. Dalbeni A; Susca N; Daidone M; Rossi I; Giontella A; Cimellaro A; Talerico G; Pietrangelo A; Sesti G; Zaccone V; Villani R; Intern Emerg Med; 2023 Nov; 18(8):2311-2319. PubMed ID: 37751084 [TBL] [Abstract][Full Text] [Related]
2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
3. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Corradini E; Ventura P; Ageno W; Cogliati CB; Muiesan ML; Girelli D; Pirisi M; Gasbarrini A; Angeli P; Querini PR; Bosi E; Tresoldi M; Vettor R; Cattaneo M; Piscaglia F; Brucato AL; Perlini S; Martelletti P; Pontremoli R; Porta M; Minuz P; Olivieri O; Sesti G; Biolo G; Rizzoni D; Serviddio G; Cipollone F; Grassi D; Manfredini R; Moreo GL; Pietrangelo A; Intern Emerg Med; 2021 Jun; 16(4):1005-1015. PubMed ID: 33893976 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study. Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493 [TBL] [Abstract][Full Text] [Related]
5. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx). Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial. Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910 [TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M; Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R; JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924 [TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study. Russo V; Di Maio M; Attena E; Silverio A; Scudiero F; Celentani D; Lodigiani C; Di Micco P Pharmacol Res; 2020 Sep; 159():104965. PubMed ID: 32474087 [TBL] [Abstract][Full Text] [Related]
13. Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study. Maamar A; Liard C; Doucet W; Reizine F; Painvin B; Delamaire F; Coirier V; Quelven Q; Guillot P; Lesouhaitier M; Tadié JM; Gacouin A Virol J; 2022 Sep; 19(1):145. PubMed ID: 36085163 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals. Bergman ZR; Usher M; Olson A; Chipman JG; Brunsvold ME; Beilman G; Tignanelli C; Lusczek ER JAMA Netw Open; 2022 Mar; 5(3):e220873. PubMed ID: 35238935 [TBL] [Abstract][Full Text] [Related]
17. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy. Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317 [TBL] [Abstract][Full Text] [Related]
19. Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea. Son M; Noh MG; Lee JH; Seo J; Park H; Yang S Medicine (Baltimore); 2021 Jul; 100(30):e26670. PubMed ID: 34397693 [TBL] [Abstract][Full Text] [Related]
20. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F; Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]